Total Payments
$3,723
2024 Payments
$329.55
Companies
32
Transactions
212
Medicare Patients
6,155
Medicare Billing
$868,792
Payment Breakdown by Category
Food & Beverage$3,682 (98.9%)
Education$40.69 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,682 | 210 | 98.9% |
| Education | $40.69 | 2 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $827.35 | 53 | $0 (2024) |
| GlaxoSmithKline, LLC. | $719.56 | 60 | $0 (2024) |
| Grifols USA, LLC | $306.66 | 17 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $262.00 | 15 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $175.62 | 5 | $0 (2022) |
| Merck Sharp & Dohme LLC | $167.74 | 8 | $0 (2023) |
| Seagen Inc. | $125.00 | 1 | $0 (2021) |
| Pharming Healthcare, Inc. | $124.74 | 1 | $0 (2023) |
| GENZYME CORPORATION | $113.56 | 5 | $0 (2024) |
| Genentech USA, Inc. | $95.62 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $329.55 | 16 | AstraZeneca Pharmaceuticals LP ($84.58) |
| 2023 | $595.57 | 23 | Pharming Healthcare, Inc. ($124.74) |
| 2022 | $348.70 | 20 | AstraZeneca Pharmaceuticals LP ($139.65) |
| 2021 | $489.13 | 21 | Seagen Inc. ($125.00) |
| 2020 | $359.42 | 17 | Novartis Pharmaceuticals Corporation ($120.24) |
| 2019 | $408.22 | 25 | AstraZeneca Pharmaceuticals LP ($111.64) |
| 2018 | $440.23 | 35 | GlaxoSmithKline, LLC. ($185.57) |
| 2017 | $752.36 | 55 | GlaxoSmithKline, LLC. ($164.30) |
All Payment Transactions
212 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $18.31 | General |
| Category: Medical Device | ||||||
| 08/15/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Hyperkalemia | ||||||
| 06/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $32.85 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Respiratory | ||||||
| 05/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.15 | General |
| Category: Immunology | ||||||
| 05/08/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Pulmonology | ||||||
| 04/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: IMMUNOLOGY | ||||||
| 04/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: RESPIRATORY | ||||||
| 02/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Respiratory | ||||||
| 01/30/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 01/16/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.60 | General |
| 01/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/19/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/08/2023 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Respiratory | ||||||
| 09/14/2023 | Pharming Healthcare, Inc. | JOENJA (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: APDS | ||||||
| 09/13/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Respiratory | ||||||
| 09/12/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Respiratory | ||||||
| 08/29/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,391 | 2,004 | $361,138 | $173,892 |
| 2022 | 14 | 1,530 | 2,246 | $433,034 | $212,063 |
| 2021 | 14 | 1,420 | 2,220 | $431,460 | $213,728 |
| 2020 | 16 | 1,814 | 2,922 | $542,310 | $269,108 |
Total Patients
6,155
Total Services
9,392
Medicare Billing
$868,792
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 213 | 425 | $58,650 | $39,579 | 67.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 89 | 225 | $84,375 | $37,311 | 44.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 196 | 342 | $55,308 | $30,771 | 55.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 119 | 123 | $33,210 | $15,907 | 47.9% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 17 | 17 | $24,565 | $8,599 | 35.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 61 | $13,855 | $7,929 | 57.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 16 | 16 | $22,320 | $7,557 | 33.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 144 | 151 | $16,308 | $6,245 | 38.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 71 | 89 | $9,167 | $5,544 | 60.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 143 | 150 | $17,100 | $4,404 | 25.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 130 | 135 | $14,040 | $4,162 | 29.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $4,830 | $2,971 | 61.5% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 174 | 247 | $7,410 | $2,913 | 39.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 106 | 269 | $100,875 | $46,142 | 45.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 246 | 527 | $72,726 | $42,674 | 58.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 222 | 383 | $56,684 | $35,044 | 61.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 159 | 168 | $45,360 | $26,329 | 58.0% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 34 | 34 | $49,130 | $17,140 | 34.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 18 | 19 | $26,505 | $9,353 | 35.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 60 | 62 | $12,765 | $8,180 | 64.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 136 | 140 | $15,120 | $6,107 | 40.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 68 | 97 | $9,991 | $5,521 | 55.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $7,980 | $4,600 | 57.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 119 | 122 | $12,688 | $3,943 | 31.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 118 | 120 | $13,680 | $3,499 | 25.6% |
About Dr. Zahid Mughal, MD
Dr. Zahid Mughal, MD is a Pulmonary Disease healthcare provider based in Hopewell, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073582540.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Zahid Mughal, MD has received a total of $3,723 in payments from pharmaceutical and medical device companies, with $329.55 received in 2024. These payments were reported across 212 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,682).
As a Medicare-enrolled provider, Mughal has provided services to 6,155 Medicare beneficiaries, totaling 9,392 services with total Medicare billing of $868,792. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Hopewell, VA
- Active Since 03/16/2006
- Last Updated 02/18/2014
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1073582540
Products in Payments
- NUCALA (Biological) $263.56
- TRELEGY ELLIPTA (Drug) $234.14
- BEVESPI AEROSPHERE (Drug) $203.65
- Prolastin-C Liquid (Biological) $198.11
- DUPIXENT (Biological) $185.23
- ANORO (Drug) $173.37
- FASENRA (Biological) $153.89
- ACTHAR (Biological) $137.01
- BELSOMRA (Drug) $127.04
- BREZTRI (Drug) $126.53
- PADCEV (Biological) $125.00
- JOENJA (Drug) $124.74
- FASENRA (Drug) $108.68
- Prolastin-C (Biological) $108.55
- Esbriet (Biological) $103.01
- ADAKVEO (Biological) $101.94
- OFEV (Drug) $99.19
- STIOLTO RESPIMAT (Drug) $90.06
- SYMBICORT (Drug) $79.54
- TEZSPIRE (Biological) $77.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.